http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105431413-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-34 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
| filingDate | 2014-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105431413-B |
| titleOfInvention | Pyrrolamide derivatives substituted by glyoxylamide and their use as medicines for treating hepatitis B |
| abstract | HBV replication inhibitors with formula (IA) Including its stereochemically isomeric forms, and salts, hydrates, solvates, wherein X and R1 to R6 have the meaning as defined herein. The invention also relates to processes for the preparation of said compounds, pharmaceutical compositions containing them and their use in HBV therapy alone or in combination with other HBV inhibitors. |
| priorityDate | 2013-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.